J2788 HCPCS code: Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)
J2788 is the HCPCS Level II code for injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.). In 2023 Medicare paid an average of $17.95 per service for J2788 across 13 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 1 per day on outpatient hospital claims. Medicare volume rose 8% from 2022 to 2023 (12 to 13 services). In 2023, about 2 clinicians billed Medicare for J2788 for 13 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2003-01-01 |
| Last action effective | 2014-01-01 |
Who bills J2788 (2023)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 2 |
| Medicare beneficiaries | 13 |
| States with claims | 1 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2788, 2022–2023
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 12 | 12 | $20.70 | $16.54 |
| 2023 | 13 | 13 | $22.54 | $17.95 |
States with the most J2788 services (2023)
| State | Services | Avg. paid |
|---|---|---|
| New York | 12 | $19.45 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 1 | Prescribing Information |
| practitioner claims | 1 | Prescribing Information |
Medicare policy articles for this code
- A57160: Billing and Coding: Immune Thrombocytopenia (ITP) Therapy (CGS Administrators, LLC (MAC - Part A, MAC - Part B))
Covered diagnoses (1 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| D69.3 | Immune thrombocytopenic purpura | 1 |
What changed for J2788
- 2003-01-01: J2788 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2788?
J2788 is the HCPCS Level II code for injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.). Short descriptor: "Rho d immune globulin 50 mcg".
How much does Medicare pay for J2788?
In 2023, the average Medicare payment was $17.95 per service (average allowed $22.54).
Does Medicare cover J2788?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
Which diagnoses support coverage for J2788?
Medicare policy articles that cite J2788 list 1 covered ICD-10-CM diagnosis codes across 1 article. The most cited include D69.3 (Immune thrombocytopenic purpura). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of J2788 can be billed per day?
1 on outpatient hospital claims; 1 on practitioner claims (NCCI medically unlikely edits).
Related J27 codes
- J2700 — Injection, oxacillin sodium, up to 250 mg
- J2704 — Injection, propofol, 10 mg
- J2710 — Injection, neostigmine methylsulfate, up to 0.5 mg
- J2711 — Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
- J2720 — Injection, protamine sulfate, per 10 mg
- J2724 — Injection, protein c concentrate, intravenous, human, 10 iu
- J2725 — Injection, protirelin, per 250 mcg
- J2730 — Injection, pralidoxime chloride, up to 1 gm
- J2760 — Injection, phentolamine mesylate, up to 5 mg
- J2765 — Injection, metoclopramide hcl, up to 10 mg
- J2770 — Injection, quinupristin/dalfopristin, 500 mg (150/350)
- J2777 — Injection, faricimab-svoa, 0.1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2788
- Watch J2788 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2788
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.